[1] ŠŤASTNÝ M,ŘÍHOVÁ B.Escape strategies of tumors from immune surveillence[J].Klin Onkol,2015,28 Suppl 4:4S28.
[2] GFELLER D,BASSANI-STERNBERG M,SCHMIDT J,et al.Current tools for predicting cancer-specific T cell immunity[J].Oncoimmunology,2016,5(7):e1177691.
[3] MOHME M,RIETHDORF S,PANTEL K.Circulating and disseminated tumour cells-mechanisms of immune surveillance and escape[J].Nat Rev Clin Oncol,2017,14(3):155.
[4] LIU C,WORKMAN CJ,VIGNALI DA.Targeting regulatory T cells in tumors[J].FEBS J,2016,283(14):2731.
[5] DIMELOE S,BURGENER AV,GRAHLERT J,et al.T-cell metabolism governing activation,proliferation and differentiation;a modular view[J].Immunology,2017,150(1):35.
[6] FREY AB.Suppression of T cell responses in the tumor microenvironment[J].Vaccine,2015,33(51):7393.
[7] LAIDLAW BJ,CRAFT JE,KAECH SM.The multifaceted role of CD4(+) T cells in CD8(+) T cell memory[J].Nat Rev Immunol,2016,16(2):102.
[8] KWAK Y,KOH J,KIM DW,et al.Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer[J].Oncotarget,2016,7(49):81778.
[9] LI Y,WU Z,LI J,et al.CD4(+)/CD8(-) T-cell large granular lymphocytic leukemia:one case report and literatures reviews[J].Zhonghua Xue Ye Xue Za Zhi,2015,36(9):739.
[10] CAZA T,LANDAS S.Functional and Phenotypic Plasticity of CD4(+) T Cell Subsets[J].Biomed Res Int,2015,2015:521957.
[11] KAPUR LH,KHALED Y,SOLH M,et al.De novo CD3 negative hepatosplenic T-cell lymphoma:diagnostic challenges and pitfalls[J].Arch Pathol Lab Med,2014,138(7):969.
[12] LI L,YANG L,WWANG L,et al.Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages[J].Int J Cancer,2016,139(10):2261.
[13] KANG X,ZHANG X,LIU Z,et al.Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-beta/beta-catenin pathway[J].Mol Hum Reprod,2016,22(7):499.
[14] 严健,原永明,张舒,等.CD3+、CD4+、CD8+T淋巴细胞亚群在肿瘤患者外周血中检测的临床意义[J].检验医学,2013,28(10):901.
[15] SUKARI A,NAGASAKA M,AL-HADIDI A,et al.Cancer Immunology and Immunotherapy[J].Anticancer Res,2016,36(11):5593.